Related Experiment Videos

[Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study]

Pilar de Lucas-Ramos1, José Luis Izquierdo-Alonso, José Miguel Rodríguez-González Moro

  • 1Servicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, España. plucasr.hgugm@salud.madrid.org

Archivos De Bronconeumologia
|May 2, 2008
PubMed

Insights

Cardiovascular risk factors are highly prevalent in patients with chronic obstructive pulmonary disease (COPD). Cardiovascular disease prevalence in COPD patients exceeds general population rates, independent of disease severity.

Area of Science:

  • Pulmonology
  • Cardiology
  • Epidemiology

Context:

  • Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic obstructive pulmonary disease (COPD).
  • The relationship between COPD and CVD is complex, with ongoing debate about whether traditional risk factors or COPD itself drives this comorbidity.
  • Understanding this association is crucial for managing COPD patients effectively.

Purpose:

  • To investigate the prevalence of cardiovascular risk factors and comorbidities in a community-based COPD population.
  • To determine if COPD severity correlates with the presence of cardiovascular disease.
  • To analyze the impact of traditional risk factors on cardiovascular health in COPD patients.

Summary:

  • A cross-sectional study of 572 COPD patients revealed high rates of hypertension (53%), obesity (27%), dyslipidemia (26%), and diabetes (23%).
  • Prevalence of ischemic heart disease (16.4%), cerebrovascular disease (7%), and peripheral vascular disease (17%) was significant.
  • Cardiovascular comorbidity was not associated with COPD severity but showed a trend with age and traditional risk factors.

Impact:

  • Cardiovascular risk factors are highly prevalent in COPD patients, contributing to increased comorbidity.
  • The observed rates of cardiovascular and cerebrovascular disease surpass those in the general population.
  • These findings underscore the need for proactive cardiovascular risk management in individuals with COPD, irrespective of airflow obstruction severity.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...